Delivery Order SPE2DR25D1017-SPE2DR26F9DGL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,773.72 to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of Lenvima 18 mg daily dose in a 90-count package. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of February 4, 2026, to be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order valued at $10,773.72 to AmerisourceBergen Drug Corp for Lenvima 18 mg daily dose, a 90-day supply. The contract is a firm fixed price delivery order with an ultimate completion date of December 2, 2025, and was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,773.72 for Lenvima 14 mg daily dose (60-count supply) on December 23, 2025, with an ultimate completion date of January 15, 2026. This firm fixed-price contract represents a non-set-aside competitive award and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for LENVIMA 14 mg daily dose (60-count supply) valued at $10,773.72 on November 24, 2025, with completion expected by December 16, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The performance location is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. LENVIMA (lenvatinib) is a targeted cancer therapy...
- The Defense Logistics Agency awarded a delivery order valued at $10,223.24 to AmerisourceBergen Drug Corp for LENVIMA 10 mg daily dose 30-count supply on July 29, 2025, with completion scheduled for August 19, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. LENVIMA (lenvatinib) is a targeted cancer therapy used to treat various malignancies,...
- The Defense Logistics Agency awarded a $10,773.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Lenvima 18 mg daily dose medication in 90-count units. The contract, which is not set-aside and carries an ultimate completion date of January 27, 2026, represents a competitively awarded purchase under AmerisourceBergen's broader pharmaceutical supply framework with the federal government. AmerisourceBergen, headquartered in Conshohocken,...
- On January 14, 2026, the Defense Logistics Agency awarded a $43,094.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Lenvima 4 mg capsules (30-count units). This is a non-set-aside competitive award with an ultimate completion date of February 5, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with parent company Cencora, Inc. (doing business as AmerisourceBergen) holding the underlying...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lenvima 10 mg daily dose (30-count supply) under a firm fixed price contract valued at $10,223.24. The order is scheduled for completion by August 27, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform at its corporate office location and deliver the pharmaceutical product as part of its extensive federal medical...
- The Defense Logistics Agency awarded a $10,773.72 delivery order to AmerisourceBergen Drug Corp for LENVIMA 14 mg daily dose tablets (60-count supply) on January 5, 2026, with completion targeted for January 27, 2026. This firm fixed-price contract represents a non-set-aside competitive award to the pharmaceutical distributor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $10,773.72 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Lenvima 18 mg daily dose in a 90-day supply quantity. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled from AmerisourceBergen's...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9DGLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,773.72 to AmerisourceBergen Drug Corp for Lenvima 10 mg daily dose (30-count supply) with a completion date of February 6, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. Lenvima is a specialty oncology medication used in cancer treatment, reflecting the breadth of pharmaceutical products supplied through this comprehensive medical supply vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal military and healthcare systems. The company's performance under the DLA IDC demonstrates its capability to supply diverse pharmaceutical commodities including specialty medications, brand-name and generic drugs, and medical supplies to support military treatment facilities, veteran healthcare programs, and other federal medical institutions globally. This delivery order is one of numerous task orders executed under the prime contract vehicle, showcasing the company's ongoing role in supplying essential pharmaceutical products to the defense medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.8k | 1/14/26 |